Open access
Oct 2026
Vaccination targeting the novel endogenous tumor-associated antigen Gpr149 induces protective immunity against checkpoint inhibitor-refractory SB28 glioblastoma
Emily E. Steffke, T. Hana, Laila Latifi et al.
· bioRxiv · 0 citations